Hot Features
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company’s pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarco... OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company’s pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.02 | 1.09289617486 | 1.83 | 2.25 | 1.732 | 1153810 | 1.99737674 | CS |
| 4 | 0.03 | 1.64835164835 | 1.82 | 2.25 | 1.625 | 654279 | 1.88969822 | CS |
| 12 | 0.6 | 48 | 1.25 | 2.25 | 1.23 | 773719 | 1.76060257 | CS |
| 26 | 0.44 | 31.2056737589 | 1.41 | 2.25 | 1.15 | 671281 | 1.60958475 | CS |
| 52 | -0.1 | -5.12820512821 | 1.95 | 2.57 | 1.15 | 578268 | 1.74330217 | CS |
| 156 | -2.15 | -53.75 | 4 | 7 | 1.12 | 518845 | 2.15524523 | CS |
| 260 | -2.15 | -53.75 | 4 | 7 | 1.12 | 518845 | 2.15524523 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.